Literature DB >> 23184526

EptC of Campylobacter jejuni mediates phenotypes involved in host interactions and virulence.

Thomas W Cullen1, John P O'Brien, David R Hendrixson, David K Giles, Rhonda I Hobb, Stuart A Thompson, Jennifer S Brodbelt, M Stephen Trent.   

Abstract

Campylobacter jejuni is a natural commensal of the avian intestinal tract. However, the bacterium is also the leading cause of acute bacterial diarrhea worldwide and is implicated in development of Guillain-Barré syndrome. Like many bacterial pathogens, C. jejuni assembles complex surface structures that interface with the surrounding environment and are involved in pathogenesis. Recent work in C. jejuni identified a gene encoding a novel phosphoethanolamine (pEtN) transferase, EptC (Cj0256), that plays a promiscuous role in modifying the flagellar rod protein, FlgG; the lipid A domain of lipooligosaccharide (LOS); and several N-linked glycans. In this work, we report that EptC catalyzes the addition of pEtN to the first heptose sugar of the inner core oligosaccharide of LOS, a fourth enzymatic target. We also examine the role pEtN modification plays in circumventing detection and/or killing by host defenses. Specifically, we show that modification of C. jejuni lipid A with pEtN results in increased recognition by the human Toll-like receptor 4-myeloid differentiation factor 2 (hTLR4-MD2) complex, along with providing resistance to relevant mammalian and avian antimicrobial peptides (i.e., defensins). We also confirm the inability of aberrant forms of LOS to activate Toll-like receptor 2 (TLR2). Most exciting, we demonstrate that strains lacking eptC show decreased commensal colonization of chick ceca and reduced colonization of BALB/cByJ mice compared to wild-type strains. Our results indicate that modification of surface structures with pEtN by EptC is key to its ability to promote commensalism in an avian host and to survive in the mammalian gastrointestinal environment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23184526      PMCID: PMC3553815          DOI: 10.1128/IAI.01046-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

Review 1.  Diversity of endotoxin and its impact on pathogenesis.

Authors:  M Stephen Trent; Christopher M Stead; An X Tran; Jessica V Hankins
Journal:  J Endotoxin Res       Date:  2006

2.  Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice.

Authors:  Z Pei; C Burucoa; B Grignon; S Baqar; X Z Huang; D J Kopecko; A L Bourgeois; J L Fauchere; M J Blaser
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

3.  A phosphoethanolamine transferase specific for the outer 3-deoxy-D-manno-octulosonic acid residue of Escherichia coli lipopolysaccharide. Identification of the eptB gene and Ca2+ hypersensitivity of an eptB deletion mutant.

Authors:  C Michael Reynolds; Suzanne R Kalb; Robert J Cotter; Christian R H Raetz
Journal:  J Biol Chem       Date:  2005-03-28       Impact factor: 5.157

4.  Colonization of chicks by motility mutants of Campylobacter jejuni demonstrates the importance of flagellin A expression.

Authors:  T M Wassenaar; B A van der Zeijst; R Ayling; D G Newell
Journal:  J Gen Microbiol       Date:  1993-06

5.  Identification of cptA, a PmrA-regulated locus required for phosphoethanolamine modification of the Salmonella enterica serovar typhimurium lipopolysaccharide core.

Authors:  R Tamayo; B Choudhury; A Septer; M Merighi; R Carlson; J S Gunn
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

6.  Changes in flagellin glycosylation affect Campylobacter autoagglutination and virulence.

Authors:  Patricia Guerry; Cheryl P Ewing; Michael Schirm; Maria Lorenzo; John Kelly; Dawn Pattarini; Gary Majam; Pierre Thibault; Susan Logan
Journal:  Mol Microbiol       Date:  2006-04       Impact factor: 3.501

Review 7.  Human beta-defensins.

Authors:  M Pazgier; D M Hoover; D Yang; W Lu; J Lubkowski
Journal:  Cell Mol Life Sci       Date:  2006-06       Impact factor: 9.261

8.  The lipid A 1-phosphatase of Helicobacter pylori is required for resistance to the antimicrobial peptide polymyxin.

Authors:  An X Tran; Judy D Whittimore; Priscilla B Wyrick; Sara C McGrath; Robert J Cotter; M Stephen Trent
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

9.  Periplasmic cleavage and modification of the 1-phosphate group of Helicobacter pylori lipid A.

Authors:  An X Tran; Mark J Karbarz; Xiaoyuan Wang; Christian R H Raetz; Sara C McGrath; Robert J Cotter; M Stephen Trent
Journal:  J Biol Chem       Date:  2004-10-15       Impact factor: 5.157

10.  Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates.

Authors:  S Baqar; A L Bourgeois; P J Schultheiss; R I Walker; D M Rollins; R L Haberberger; O R Pavlovskis
Journal:  Vaccine       Date:  1995-01       Impact factor: 3.641

View more
  35 in total

1.  Extracellular zinc induces phosphoethanolamine addition to Pseudomonas aeruginosa lipid A via the ColRS two-component system.

Authors:  Emily M Nowicki; John P O'Brien; Jennifer S Brodbelt; M Stephen Trent
Journal:  Mol Microbiol       Date:  2015-05-09       Impact factor: 3.501

2.  Structure of a lipid A phosphoethanolamine transferase suggests how conformational changes govern substrate binding.

Authors:  Anandhi Anandan; Genevieve L Evans; Karmen Condic-Jurkic; Megan L O'Mara; Constance M John; Nancy J Phillips; Gary A Jarvis; Siobhan S Wills; Keith A Stubbs; Isabel Moraes; Charlene M Kahler; Alice Vrielink
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

3.  Substrate structure-activity relationship reveals a limited lipopolysaccharide chemotype range for intestinal alkaline phosphatase.

Authors:  Gloria Komazin; Michael Maybin; Ronald W Woodard; Thomas Scior; Dominik Schwudke; Ursula Schombel; Nicolas Gisch; Uwe Mamat; Timothy C Meredith
Journal:  J Biol Chem       Date:  2019-11-08       Impact factor: 5.157

Review 4.  Polymyxin: Alternative Mechanisms of Action and Resistance.

Authors:  Michael J Trimble; Patrik Mlynárčik; Milan Kolář; Robert E W Hancock
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

5.  Ultraviolet Photodissociation Mass Spectrometry for Analysis of Biological Molecules.

Authors:  Jennifer S Brodbelt; Lindsay J Morrison; Inês Santos
Journal:  Chem Rev       Date:  2019-12-18       Impact factor: 60.622

6.  UVliPiD: A UVPD-Based Hierarchical Approach for De Novo Characterization of Lipid A Structures.

Authors:  Lindsay J Morrison; W Ryan Parker; Dustin D Holden; Jeremy C Henderson; Joseph M Boll; M Stephen Trent; Jennifer S Brodbelt
Journal:  Anal Chem       Date:  2016-01-15       Impact factor: 6.986

7.  Characterization of Two Novel Lipopolysaccharide Phosphoethanolamine Transferases in Pasteurella multocida and Their Role in Resistance to Cathelicidin-2.

Authors:  Marina Harper; Amy Wright; Frank St Michael; Jianjun Li; Deanna Deveson Lucas; Mark Ford; Ben Adler; Andrew D Cox; John D Boyce
Journal:  Infect Immun       Date:  2017-10-18       Impact factor: 3.441

Review 8.  Molecular Mechanisms of Campylobacter Biofilm Formation and Quorum Sensing.

Authors:  Christoph Püning; Yulan Su; Xiaonan Lu; Greta Gölz
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

9.  Characterization of Lipid A Variants by Energy-Resolved Mass Spectrometry: Impact of Acyl Chains.

Authors:  Christopher M Crittenden; Lucas D Akin; Lindsay J Morrison; M Stephen Trent; Jennifer S Brodbelt
Journal:  J Am Soc Mass Spectrom       Date:  2016-12-13       Impact factor: 3.109

10.  Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii.

Authors:  Mark R Pelletier; Leila G Casella; Jace W Jones; Mark D Adams; Daniel V Zurawski; Karsten R O Hazlett; Yohei Doi; Robert K Ernst
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.